Between January @ and September @ , @ CHD patients with DM who were aged @ years and undergoing coronary angiography at An Zhen Hospital ( Beijing , China ) were recruited and prospectively randomized to receive trimetazidine ( @ mg three times daily ) or placebo after DES implantation as an addition to conventional CHD treatment .